Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients.

Kappler M, Kotrba J, Kaune T, Bache M, Rot S, Bethmann D, Wichmann H, Güttler A, Bilkenroth U, Horter S, Gallwitz L, Kessler J, Greither T, Taubert H, Eckert AW, Vordermark D.

Clin Transl Radiat Oncol. 2017 Jun 27;5:6-11. doi: 10.1016/j.ctro.2017.05.002. eCollection 2017 Aug.

2.

CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.

Greither T, Wedler A, Rot S, Keßler J, Kehlen A, Holzhausen HJ, Bache M, Würl P, Taubert H, Kappler M.

Int J Mol Sci. 2017 Dec 7;18(12). pii: E2648. doi: 10.3390/ijms18122648.

3.

Automatic detection of DNA double strand breaks after irradiation using an γH2AX assay.

Hohmann T, Kessler J, Grabiec U, Bache M, Vordermark D, Dehghani F.

Histol Histopathol. 2018 May;33(5):475-485. doi: 10.14670/HH-11-945. Epub 2017 Nov 15.

PMID:
29139544
4.

miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome.

Keßler J, Rot S, Bache M, Kappler M, Würl P, Vordermark D, Taubert H, Greither T.

Oncol Lett. 2016 Dec;12(6):5281-5288. doi: 10.3892/ol.2016.5320. Epub 2016 Oct 26.

5.

IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status.

Kessler J, Güttler A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D.

Radiother Oncol. 2015 Sep;116(3):381-7. doi: 10.1016/j.radonc.2015.08.007. Epub 2015 Aug 29.

PMID:
26328938
6.

mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.

Bache M, Rot S, Keßler J, Güttler A, Wichmann H, Greither T, Wach S, Taubert H, Söling A, Bilkenroth U, Kappler M, Vordermark D.

Oncol Rep. 2015 Jun;33(6):3155-61. doi: 10.3892/or.2015.3932. Epub 2015 Apr 27.

PMID:
25963717
7.

Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells.

Wichmann H, Güttler A, Bache M, Taubert H, Rot S, Kessler J, Eckert AW, Kappler M, Vordermark D.

Strahlenther Onkol. 2015 Feb;191(2):180-91. doi: 10.1007/s00066-014-0743-9. Epub 2014 Aug 27.

PMID:
25159136
8.

Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.

Güttler A, Giebler M, Cuno P, Wichmann H, Keßler J, Ostheimer C, Söling A, Strauss C, Illert J, Kappler M, Vordermark D, Bache M.

Radiother Oncol. 2013 Sep;108(3):535-40. doi: 10.1016/j.radonc.2013.06.036. Epub 2013 Jul 25.

PMID:
23891093
9.

Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.

Bache M, Zschornak MP, Passin S, Kessler J, Wichmann H, Kappler M, Paschke R, Kaluđerović GN, Kommera H, Taubert H, Vordermark D.

Radiat Oncol. 2011 Sep 9;6:111. doi: 10.1186/1748-717X-6-111.

10.

HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.

Kessler J, Hahnel A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D.

BMC Cancer. 2010 Nov 4;10:605. doi: 10.1186/1471-2407-10-605.

Supplemental Content

Loading ...
Support Center